BNP/PUT/ELI LILLY & CO/750/0.1/20.12.24 | Market Closed - Boerse Frankfurt Warrants 01:20:40 28/06/2024 am IST | ||
| 1.75 EUR | -4.89% |
|
| Current month | -52.57% | ||
| 1 month | -54.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 1.75 | -4.89% |
| 26/24/26 | 1.84 | +2.79% |
| 25/24/25 | 1.79 | -5.79% |
| 24/24/24 | 1.9 | -8.65% |
| 21/24/21 | 2.08 | -1.42% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PC7ZJC |
| ISIN | DE000PC7ZJC7 |
| Date issued | 09/04/2024 |
| Strike | 750 $ |
| Maturity | 20/12/2024 (176 Days) |
| Parity | 10 : 1 |
| Emission price | 5.36 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.89 € |
|---|---|
| Lowest since issue | 1.67 € |
| Delta | -0.15x |
| Omega | 7.430 |
| Premium | 19.53x |
| Gearing | 49.09x |
| Moneyness | 0.8250 |
| Difference Strike | -159 $ |
| Difference Strike % | -21.21% |
| Spread | 0.02 € |
| Spread % | 1.15% |
| Theoretical value | 1.730 |
| Implied Volatility | 33.52 % |
| Total Loss Probability | 79.12 % |
| Intrinsic value | 0.000000 |
| Present value | 1.730 |
| Break even | 731.48 € |
| Theta | -0.08x |
| Vega | 0.14x |
| Rho | -0.06x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
909
USD
Average target price
860.5
USD
Spread / Average Target
-5.33%
- Stock Market
- Warrants
- Warrant
